Structure-based engineering of pH-dependent antibody binding for selective targeting of solid-tumor microenvironment

ABSTRACTRecent development of monoclonal antibodies as mainstream anticancer agents demands further optimization of their safety for use in humans. Potent targeting and/or effector activities on no...